The case for adaptive radiotherapy.

Why settling for a static treatment plan is no longer the standard for complex tumors.

Why static plans fall short

For decades, radiation oncology has operated on a fundamental compromise: because doctors could not see exactly where the tumor was on the day of treatment, they had to irradiate a larger area just in case. Adaptive radiotherapy is designed to remove that compromise.

• Tumors Shrink and Shift — Many tumors can lose a meaningful portion of their volume between the first scan and the final session.
• Daily Organ Movement — Organs in the abdomen and pelvis change size and shape daily based on digestion and hydration.

The margin problem

To compensate for uncertainty, conventional radiation relies on a Planning Target Volume (PTV): a safety margin of several millimeters added around the tumor. This guarantees that healthy tissue inside that margin is irradiated.

The adaptive solution

• Shrinking Margins — Because we image and adapt the plan immediately before turning on the beam, we do not need large safety margins.
• Protecting Healthy Tissue — By tracking the daily position of critical organs, the adaptive plan steers the radiation dose away from healthy structures.
• Fewer Side Effects — Tighter margins mean less healthy tissue is exposed.

What this means for you

• Quality of life — Protecting the bladder, bowel, salivary glands, or healthy lung helps preserve everyday function long after treatment ends.
• Less disruption — A course measured in days rather than weeks means fewer trips to the clinic.
• Confident dosing — When the target is confirmed every day, clinicians can deliver a strong, focused dose.